Example: marketing

EULAR Textbook on Rheumatic Diseases …

EULAR Textbook on Rheumatic Diseases References chapter 13 (Key references in bold print) References for Gout chapter 1. McCarty DJ, Hollander JL: Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961; 54: 452-460. 1. Pascual E, Batlle-Gualda E, Mart nez A, Rosas J, Vela P. Synovial Fluid analysis for diagnosis of intercritical gout. Ann Intern Med 1999;131:756-59 1 Pascual E, Sivera F. The time required for disappearance of urate crystals from synovial fluid after successful hypouricemic treatment relates to the duration of gout. Ann Rheum Dis 2007 Jan 12; 2007;66:1056-8 1 Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, Schumacher HR Jr. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?

EULAR Textbook on Rheumatic Diseases References chapter 13 (Key references in bold print) References for Gout chapter 1. McCarty DJ, Hollander JL: Identification of urate crystals in gouty synovial fluid.

Tags:

  Chapter, Reference, Disease, Textbook, Rheumatic, Textbook on rheumatic diseases, Textbook on rheumatic diseases references chapter 13

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Transcription of EULAR Textbook on Rheumatic Diseases …

1 EULAR Textbook on Rheumatic Diseases References chapter 13 (Key references in bold print) References for Gout chapter 1. McCarty DJ, Hollander JL: Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961; 54: 452-460. 1. Pascual E, Batlle-Gualda E, Mart nez A, Rosas J, Vela P. Synovial Fluid analysis for diagnosis of intercritical gout. Ann Intern Med 1999;131:756-59 1 Pascual E, Sivera F. The time required for disappearance of urate crystals from synovial fluid after successful hypouricemic treatment relates to the duration of gout. Ann Rheum Dis 2007 Jan 12; 2007;66:1056-8 1 Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, Schumacher HR Jr. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?

2 J Rheumatol 2001 Mar;28:577-80. 1 Perez-Ruiz F, Liote F. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Arthritis Rheum 2007; 57:1324-8 1 Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96 1 Chen SY, Chen CL, Shen ML. Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol 2007;26:308-13. 1 Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al. EULAR evidence based recommendations for gout - Part I Diagnosis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics(ESCISIT). Ann Rheum Dis 2006;65:1312-24 1 Zhang W, Doherty M, , Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J et al.

3 EULAR Evidence based recommendations for gout - part ii management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;25:1301-11 1 Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG. Quality of care indicators for gout management. Artritis Rheum 2004;50:937-43 1 Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. 2002;40:355-60. 1 Oda M, Satta Y, Takenaka O, Tanaka N, Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002;19:240-53 EULAR Textbook on Rheumatic Diseases 1 Garbagnati E, Boschetti M. Uric acid homeostasis in lean and obese girls during pubertal development.

4 Metabolism 1994;43:819-21. 1 Mikkelsen WN, Dodge HJ, Valkenburg H, Himes S. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Am J Med 1965;39:242-51 1 Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia. Am J Med 1967;42:27-37. 1 Gibson T, Rodgers AV, Simmonds HA, Toseland P. drinking and its effect on uric acid. Br J Rheumatol 1984;23:203-9 1 Maesaka JK, Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney ;32:917-33 1 Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda). 2005;20:125-33. 1 Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease .

5 Clin Exp Nephrol. 2005;9:195-205 1 Perez-Ruiz F, Calabozo M, Garc a-Erauskin G, Ruibal A, Herrero Beites AM. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 2002;47:610-3. 1 Pascual E, Perdiguero M. Gout, diuretics and the kidney. Ann Rheum Dis 2006;65:981-2. 1 Facchini F, Chen Y-D, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008 11 1 Tirahones FJ, P rez Lind n G, C-Soriguer FJ, Pareja A, S nchez Guijo P, Collantes E. Dietary alterations in plasma very low density lypoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab 1997;82:1188-91.

6 1 Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. ;59:364-8. 1 Ochiai ME, Barreto ACP, Oliveira MT, Munhoz RT, Morgado PC, Ramires JAF. Uric acid renal excretion and renal insufficiency in decompensated severe heart failure Eur J Heart Fail 2005;7:468-74 1 Lin JL, Yu CC, Lin-Tan DT, Ho HH. Lead chelation therapy and urate excretion in patients with chronic renal Diseases and gout. Kidney Int 2001;60:266-71. 1 Lin HY, Rocher LL, McQuilan MA, Schmatz S, Palella TD, Fox IH. Cyclosporine induced hyperuricemia and gout. N Eng J Med 1989;321:287-92 EULAR Textbook on Rheumatic Diseases 1 Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.

7 Arthritis Rheum 2000;43:103-108. 1 Vazquez-Mellado J, Jim nez-Vaca AL, Cuevas-Covarrubias S, Alvarado-Romano V, Pozo-Molina G, Burgos-Vargas R. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology 2007;46:215-9. 1 Pascual E, Ord ez S. Orderly arrayed deposit of urate crystals in gout suggest epitaxial formation. Ann Rheum Dis 1998;57:255. 1 Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis?. Ann Rheum Dis 2007 66:1374-7 1 Grassi W, Meenagh G, Pascual E, Filippucci E. "Crystal clear"-sonographic assessment of gout and calcium pyrophosphate deposition disease . Semin Arthritis Rheum 2006;36:197-202 1 Simkin PA. The pathogenesis of podagra. Ann Intern Med. 1977;86:230-3. 1 Faires JS, McCarty DJ. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals.

8 Lancet 1962;2:682-685 1 Malawista SE, Seegmiller JE. The effect of pretreatment with colchicine on the inflammatory response to microcrystaline urate. Ann Intern Med 1965;62:648-57 1 Rouault T, Caldwell DS, Holmes EW. Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls. Arthritis Rheum 1982; 25:209-12. 1 Pascual E: Persistence of monosodium urate crystals, and low grade inflammation, in the synovial fluid of untreated gout. Arthritis Rheum 34:141-145, 1991. 1. Grassi W, Meenagh G, Pascual E, Filippucci E. "Crystal clear"-sonographic assessment of gout and calcium pyrophosphate deposition disease . Semin Arthritis Rheum 2006;36:197-202. 1 Baker JF, Synnott KA. Clinical images: gout revealed on arthroscopy after minor injury. Arthritis Rheum 2010;62:895.

9 1 Pascual E, Jovan V. A Quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout. Brit J Rheumatol 1995;34:724-6. Pascual E, Castellano JA. Treatment with colchicine decreases the white cell counts in the synovial fluid of asymptomatic knees which contain monosodium urate crystals. J Rheumatol 1992;19:600-3. 1 Yagnik DR, Hillyer P, Marshall D, Smythe CDW, Krausz T, Haskard DO, Landis RC. Non inflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 2000;43:1779-89 EULAR Textbook on Rheumatic Diseases 1 Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC, Haskard DO. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages.

10 Arthritis Rheum. 2002; 46: 3026-33 1 Richette P, Briere C, Hoenen-Clavert V, Loeuille D, Bardin T. Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. J Rheumatol 2007; 34:2093-8 1 Bolamaski IS, Schumacher HR. Podagra is more than gout. Bull Rheum Dis1984;34:1-8. 1. Canoso JJ, Yood RA. Acute gouty bursitis. Report of 15 cases. Ann Rheum Dis 1979;38:326-8. 1. Lawry GV, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective comparative analysis of clinical features. Medicine (Baltimore)1988;67:335-343 1. Meyers OL, Monteagudo FSE. Gout in femeles: an analysis of 92 patients. Clin Exp Rheumatol 1985;3:105-109. 1. Lally EV, Ho G, Kaplan RS. The clinical spectrum of gouty arthritis in women. Arch Intern Med 1986;146;2221-5. 1. Yu T-F. Some unusual features of gouty arthritis in females.


Related search queries